-
Loading metrics
An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India
- Purushothaman Jambulingam,
- Vijesh Sreedhar Kuttiatt,
- Kaliannagounder Krishnamoorthy,
- Swaminathan Subramanian,
- Adinarayanan Srividya,
- Hari Kishan K. Raju,
- Manju Rahi,
- Roopali K. Somani,
- Mallanna K. Suryaprakash,
- Gangeshwar P. Dwivedi
x
-
- Published: February 16, 2021
- https://doi.org/10.1371/journal.pntd.0009069